BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC)
Clinical trial NCT05911633 · RECRUITING
Trial details
- NCT number
- NCT05911633
- Sponsor
- Terumo Europe N.V.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-27
- Primary completion
- 2026-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.